drugset / Trial / NCT00829868
Zaleplon 10 mg Capsules Under Non-Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to compare the relative bioavailability of zaleplon 10 mg capsules(manufactured and distributed by TEVA Pharmaceuticals USA) with that of SONATA® 10mg capsules (Wyeth-Ayerst Pharmaceuticals) in healthy, non-smoking, adult subjects under non-fasting conditions.
Timeline
- Start
- 2004-02
- Primary completion
- 2004-03
- Completion
- 2004-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zaleplon | Small molecule | 10 mg | — |
Indications
No indication recorded.